Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Clinical trial NCT00261053 · COMPLETED
Trial details
- NCT number
- NCT00261053
- Sponsor
- Pharming Technologies B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2005-09-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.